%0 Journal Article %A Reinhold Kosfeld %A Timo Mitze %A Johannes Rode %A Klaus Wälde %T The Covid-19 containment effects of public health measures - A spatial difference-in-differences approach %D 2020 %R 10.1101/2020.12.15.20248173 %J medRxiv %P 2020.12.15.20248173 %X Since mid-March 2020 the Federal and state governments in Germany agreed on comprehensive public health measures to contain the spread of Covid-19. We study the effects of the policy actions on the progression of the pandemic in the first containment period in spring 2020 before easing of measures have started to work by the end of April. To exploit both the time and spatial dimension in the dissemination of the virus, we conduct a spatial data panel analysis for German NUTS-3 regions. Specifically, we employ a spatial difference-in-differences approach to identify the effects of individual public health measures. We find that contact restrictions and closure of schools substantially contributed to flattening the infection curve. Additionally, a strong treatment effect of wearing face masks is established in the few treated regions during the containment phase. No incremental effect is evidenced for closure of establishments and shutdown of shopping malls and other stores. These findings prove to be highly robust to changes in model specification. By contrast, the dampening effect of restaurant closure is sensitive to model variation.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:no approval or exemption necessaryAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is public %U https://www.medrxiv.org/content/medrxiv/early/2020/12/16/2020.12.15.20248173.full.pdf